Andere talen Aspira Women's Health Inc.

Aandelen

AWH

US04537Y2081

Beurs gesloten - Nasdaq Andere beurzen 22:30:00 26-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
3,327 ^USD	+1,42%		-4,68%	-18,47%

01/04	ASPIRA WOMEN'S HEALTH INC. : Cantor Fitzgerald vindt het aandeel niet inspirerend	ZM
28/03	Transcript : Aspira Women's Health Inc., Q4 2023 Earnings Call, Mar 28, 2024

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Aspira Women’s Health Announces Anthem Blue Cross to Provide Coverage for OvaSuite(SM) in California	09/04
Aspira: Q4 Earnings Snapshot	28/03
Earnings Flash (AWH) ASPIRA WOMEN'S HEALTH Posts Q4 Revenue $2.1M	28/03
Aspira Women’s Health Reports Fourth Quarter and Full Year 2023 Financial Results	28/03
Aspira Women's Health Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	28/03
Aspira Women's Health Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	28/03
Aspira Women’s Health Announces New Time for its Fourth Quarter and 2023 Year End Earnings Results and Call	25/03
Aspira Women Health : Management Change/Compensation - Form 8-K	25/03
Aspira Women’s Health to Present at the MedInvest Biotech & Pharma Investor Conference	21/03
Aspira Women’s Health Expands Senior Leadership Team with the Addition of Sandra Milligan, M.D., J.D. as President	18/03
Aspira Women's Health Inc. Announces Executive Changes	18/03
Aspira Women’s Health to Announce Fourth Quarter and 2023 Year End Earnings Results and Host a Conference Call on Thursday, March 28, 2024	11/03
Aspira Women’s Health to Present at The Cancer Advocacy Group of Louisiana’s 3rd Annual NeauxCancer Conference	22/02
Aspira Women’s Health Announces Late-Breaking Poster Presentation at the Upcoming 71st Annual Scientific Meeting for the Society for Reproductive Investigation (SRI)	12/02
Aspira Women’s Health Announces OvaSuite(SM) Distribution Agreement in the Philippines	06/02
Aspira Women's Health Inc. Announces OvaSuite(SM) Distribution Agreement in the Philippines	06/02
Aspira Women’s Health Announces $5.5 Million Registered Direct Offering and Concurrent Private Placement	25/01
Aspira Women's Health Inc. announced that it expects to receive $5.5 million in funding	24/01
Aspira Women's Health Inc. Announces Resignation of Veronica G.H. Jordan from the Board of Directors	27/12
Aspira Women’s Health to Host R&D Day With Updates on the Development of the Company's Ovarian Cancer and Endometriosis Tests on January 4, 2024	19/12

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Aspira Women's Health Inc.

Aandelen

AWH

US04537Y2081

Andere talen

Filters